Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community Effectiveness of IPTi in Tanzanian Infants
NCT00152204Phase 3Unknown
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Mar 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sulfadoxine + pyrimethamine in malaria and anemia (2 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoints: Mortality rate in children aged 2-11 months and Incidence of severe adverse drug reactions following IPTi. Status: unknown.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malariaanemia
Beyond the preview
Go deeper on NCT00152204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152204.